Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom.
Endocr Rev. 2010 Oct;31(5):629-62. doi: 10.1210/er.2009-0044. Epub 2010 Apr 29.
Osteoporosis is a common disease with a strong genetic component characterized by reduced bone mass, defects in the microarchitecture of bone tissue, and an increased risk of fragility fractures. Twin and family studies have shown high heritability of bone mineral density (BMD) and other determinants of fracture risk such as ultrasound properties of bone, skeletal geometry, and bone turnover. Osteoporotic fractures also have a heritable component, but this reduces with age as environmental factors such as risk of falling come into play. Susceptibility to osteoporosis is governed by many different genetic variants and their interaction with environmental factors such as diet and exercise. Notable successes in identification of genes that regulate BMD have come from the study of rare Mendelian bone diseases characterized by major abnormalities of bone mass where variants of large effect size are operative. Genome-wide association studies have also identified common genetic variants of small effect size that contribute to regulation of BMD and fracture risk in the general population. In many cases, the loci and genes identified by these studies had not previously been suspected to play a role in bone metabolism. Although there has been extensive progress in identifying the genes and loci that contribute to the regulation of BMD and fracture over the past 15 yr, most of the genetic variants that regulate these phenotypes remain to be discovered.
骨质疏松症是一种常见的疾病,具有很强的遗传成分,其特征是骨量减少、骨组织微结构缺陷以及脆性骨折风险增加。双胞胎和家族研究表明,骨矿物质密度(BMD)和其他骨折风险决定因素(如骨超声特性、骨骼几何形状和骨转换)具有很高的遗传性。骨质疏松性骨折也具有遗传成分,但随着年龄的增长,环境因素(如跌倒风险)的作用,这种遗传成分会减少。骨质疏松症的易感性受许多不同的遗传变异及其与环境因素(如饮食和运动)的相互作用的影响。通过研究罕见的孟德尔骨骼疾病,这些疾病的骨骼质量存在严重异常,其中存在大效应大小的变异,从而在调节 BMD 方面取得了显著成功。全基因组关联研究也鉴定了常见的遗传变异,其对一般人群中 BMD 和骨折风险的调节具有小效应大小的作用。在许多情况下,这些研究确定的位点和基因以前并未被怀疑在骨代谢中发挥作用。尽管在过去 15 年中,在确定调节 BMD 和骨折的基因和位点方面已经取得了广泛的进展,但调节这些表型的大多数遗传变异仍有待发现。